A. Robertson

P38α Regulates Expression of DUX4 in Facioscapulohumeral Muscular Dystrophy

S. Kazmirski, L. Ronco, A. Cacace, 2019, bioRxiv.

p38α Regulates Expression of DUX4 in a Model of Facioscapulohumeral Muscular Dystrophy

S. Kazmirski, L. Ronco, A. Cacace, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents

M. Ahlijanian, L. Bristow, N. Devidze, 2017, Neuromuscular Disorders.

Synergistic inhibition of A&bgr; production by combinations of &ggr;‐secretase modulators

M. Banks, M. Ahlijanian, D. Drexler, 2017, European journal of pharmacology.

Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780

J. Macor, M. Ahlijanian, Joseph L. Cantone, 2014, International journal of Alzheimer's disease.

Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects

H. Soares, J. Macor, M. Ahlijanian, 2016, The Journal of Pharmacology and Experimental Therapeutics.